Among the rare ocular side effects of GLP-1RAs is non-arteritic anterior ischemic optic neuropathy (NAION), which can cause permanent loss of vision, states the report, Glucagon-like Peptide-1 Receptor Agonists and Ocular Health: Guidance for Optometric Practice. The report was first presented at the 2025 Optometry's Meeting | 5th World Congress of Optometry and is meant to provide critical guidance to doctors of optometry treating patients on GLP-1RAs
Regular follow-ups with a healthcare provider are essential to monitor progress and adjust dosages as needed
In contrast to drugs that raise heart rate through direct cardiac stimulation, incretin-based therapies seem to act through central autonomic pathways
The first platform built for serious peptide research
Everyone has been lying saying, Oh smaller portions, she said
Keep these separate from water-reconstituted peptides different solvents, different vials